Welcome to industryreportstore.com

Need help? +44(0)20 7936 6830

Musculoskeletal market research, reports and industry analysis

mail

Contact us for professional industry advice

Email us or call

+44(0)20 7936 6830
mail

for FREE research alerts
to your inbox

152 Item(s)

Page 1 of 16

  1. PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

    By: GlobalData
    , Published: Dec-2016
    , Product code: GDHC140PIDR
    Psoriatic arthritis (PsA) is a chronic immune-mediated arthritis typically affecting the large joints, especially those of the lower extremities and distal joints of the fingers and toes as well as the back and sacroiliac joints of the pelvis. In approximately 80% of PsA patients, skin lesions of psoriasis (PsO), an immune-mediated skin disease, manifest prior to the development of PsA, typically by five to 10 years. PsA most commonly develops between the ages of 30 and 50 and affects men and women equally. Although, early diagnosis and intervention are key in preventing irreversible joint damage, many PsA patients are undiagnosed and go untreated for months or years.
    $10,995.00

  2. EpiCast Report: Psoriatic Arthritis - Epidemiology Forecast to 2025

    By: GlobalData
    , Published: Dec-2016
    , Product code: GDHCER134-16
    Psoriatic arthritis (PsA) is a chronic inflammatory arthropathy that may be progressive in nature and can lead to severe joint damage and disability. The disease is considered to be rare in the general population, but PsA may affect up to 30% of persons with psoriasis (Ogdie and Gelfand, 2011; NPF, 2016).
    $3,995.00

  3. Pigmented Villonodular Synovitis - Pipeline Review, H2 2016

    By: Global Markets Direct
    , Published: Nov-2016
    , Product code: GMDHC8714IDB
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pigmented Villonodular Synovitis – Pipeline Review, H2 2016, provides an overview of the Pigmented Villonodular Synovitis (Musculoskeletal Disorders) pipeline landscape.
    $2,000.00

  4. Polyarticular Juvenile Idiopathic Arthritis (PJIA) - Pipeline Review, H2 2016

    By: Global Markets Direct
    , Published: Nov-2016
    , Product code: GMDHC8738IDB
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Polyarticular Juvenile Idiopathic Arthritis (PJIA) – Pipeline Review, H2 2016, provides an overview of the Polyarticular Juvenile Idiopathic Arthritis (PJIA) (Musculoskeletal Disorders) pipeline landscape.
    $2,000.00

  5. Axial Spondyloarthritis - Pipeline Review, H2 2016

    By: Global Markets Direct
    , Published: Nov-2016
    , Product code: GMDHC8764IDB
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Axial Spondyloarthritis - Pipeline Review, H2 2016, provides an overview of the Axial Spondyloarthritis (Musculoskeletal Disorders) pipeline landscape.
    $2,000.00

  6. Dermatomyositis - Pipeline Review, H2 2016

    By: Global Markets Direct
    , Published: Nov-2016
    , Product code: GMDHC8765IDB
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dermatomyositis - Pipeline Review, H2 2016, provides an overview of the Dermatomyositis (Musculoskeletal Disorders) pipeline landscape.
    $2,000.00

  7. Osteonecrosis - Pipeline Review, H2 2016

    By: Global Markets Direct
    , Published: Nov-2016
    , Product code: GMDHC8699IDB
    Osteonecrosis is bone death caused by poor blood supply to the area. It is most common in the hip and shoulder, but can affect other large joints such as knee, elbow, wrist and ankle. Osteonecrosis can be caused by disease, or a severe trauma, such as a break or dislocation, that affects the blood supply to the bone. There are no symptoms in the early stages. Symptomatic treatment is available.
    $2,000.00

  8. Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H2 2016

    By: Global Markets Direct
    , Published: Nov-2016
    , Product code: GMDHC8639IDB
    Ankylosing spondylitis is a type of arthritis that affects the spine. Ankylosing spondylitis symptoms include pain and stiffness from the neck down to the lower back. The spine's bones (vertebrae) may grow or fuse together, resulting in a rigid spine. These changes may be mild or severe, and may lead to a stooped-over posture.
    $2,000.00

  9. Muscular Dystrophy - Pipeline Review, H2 2016

    By: Global Markets Direct
    , Published: Nov-2016
    , Product code: GMDHC8655IDB
    Muscular dystrophy is a group of diseases in which muscle fibers are unusually susceptible to damage. These damaged muscles become progressively weaker. Symptoms usually appear before age 6 and may appear as early as infancy. They may include fatigue, learning difficulties, intellectual disability, muscle weakness and progressive difficulty walking.
    $2,000.00

  10. Gouty Arthritis (Gout) - Pipeline Review, H2 2016

    By: Global Markets Direct
    , Published: Nov-2016
    , Product code: GMDHC8672IDB
    Gout is a type of arthritis where swelling and severe pain develops in joints, especially at the base of the big toe. Gout occurs when uric acid builds up in blood and causes inflammation in the joints. Symptoms include sudden onset of joint pain, joint swelling, heat in the affected area and joint redness. Risk factors include obesity, high alcohol intake, injury to a joint, long-standing kidney disease and high intake of foods rich in purines.
    $2,000.00

152 Item(s)

Page 1 of 16